![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
1. Dsernil Sandoz
2. Dsernil-sandoz
3. Deseril
4. Desril
5. Dimaleate, Methysergide
6. Dimethylergometrin
7. Maleate, Methysergide
8. Methylmethylergonovine
9. Methysergide
10. Methysergide Dimaleate
11. Sansert
12. Uml 491
13. Uml-491
14. Uml491
1. 129-49-7
2. Methysergide Maleate Salt
3. Methysergide Hydrogen Maleate
4. Deseril-retard
5. Desernil Bismaleate
6. Methysergide Maleate [usp]
7. 129-49-7 (maleate)
8. 2u7h1466gh
9. Nsc-759143
10. Methysergide Maleate (usp)
11. Methysergide Bimaleate
12. 1-methyl-d-lysergic Acid Butanolamide Dimaleate
13. Mls000069364
14. (6ar,9r)-n-[(2s)-1-hydroxybutan-2-yl]-4,7-dimethyl-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide; Maleate (1:1)
15. Ergoline-8-carboxamide,9,10-didehydro-n-[(1s)-1-(hydroxymethyl)propyl]-1,6-dimethyl-, (8b)-,(2z)-2-butenedioate (1:1) (salt)
16. Smr000058483
17. Einecs 204-950-9
18. Nsc 186061
19. Unii-2u7h1466gh
20. Sansert (tn)
21. Lysergamide, N-((1-hydroxymethyl)propyl)-1-methyl-, Maleate
22. Methysergidemaleate
23. Regid855989
24. (+)-n-((1-hydroxymethyl)propyl)-1-methyl-d-lysergamide Bimaleate
25. (6ar,9r)-n-[(2s)-1-hydroxybutan-2-yl]-4,7-dimethyl-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide;(z)-but-2-enedioic Acid
26. 1-(hydroxymethyl)propylamide Of 1-methyl-(+)-lysergic Acid Hydrogen Maleate
27. 9,10-didehydro-n-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8beta-carboxamide Maleate (1:1) (salt)
28. Mls001076153
29. Chebi:6894
30. Chembl1200938
31. Methysergide Maleate Salt, Solid
32. Schembl21803661
33. Dtxsid901017106
34. Hms2093n13
35. Hms2231l15
36. Hms3262n07
37. Hms3414j11
38. Hms3678j09
39. Hms3887o05
40. Pharmakon1600-01505492
41. Methysergide Maleate Assay Standard
42. Methysergide Maleate [vandf]
43. Tox21_500863
44. Methysergide Maleate [mart.]
45. Nsc759143
46. Methysergide Maleate [usp-rs]
47. Methysergide Maleate [who-dd]
48. Akos024456362
49. Ccg-213467
50. Lp00863
51. Ncgc00261548-01
52. Ergoline-8-beta-carboxamide, 9,10-didehydro-n-(1-(hydroxymethyl)propyl)-1,6-dimethyl-, Maleate (1:1) (salt)
53. Ergoline-8-carboxamide, 9,10-didehydro-n-((1s)-1-(hydroxymethyl)propyl)-1,6-dimethyl-, (8beta)-, (2z)-2-butenedioate (1:1) (salt)
54. Ergoline-8-carboxamide, 9,10-didehydro-n-(1-(hydroxymethyl)propyl)-1,6-dimethyl-, (8beta)-, (z)-2-butenedioate (1:1) (salt)
55. Ergoline-8beta-carboxamide, 9,10-didehydro-n-(1-(hydroxymethyl)propyl)-1,6-dimethyl-, Maleate (1:2) (salt)
56. Methysergide Hydrogen Maleate [mi]
57. Methysergide Maleate [orange Book]
58. Smr000653472
59. Methysergide Maleate [usp Impurity]
60. Methysergide Maleate [usp Monograph]
61. Eu-0100863
62. M-137
63. D00681
64. Sr-01000002986
65. Sr-01000002986-2
66. Q27255601
67. Methysergide Maleate, United States Pharmacopeia (usp) Reference Standard
68. [8?(s)]-9,10-didehydro-n-[1-(hydroxymethyl)propyl]-1,6-dimethylergoline-8-carboxamide Maleate
69. 9,10-didehydro-n-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8.beta.-carboxamide Maleate (1:1) (salt)
70. Ergoline-8-carboxamide, 9,10-didehydro-n-(1-(hydroxymethyl)propyl)-1,6-dimethyl-, (8.beta.)-, (z)-2-butenedioate (1:1) (salt)
Molecular Weight | 469.5 g/mol |
---|---|
Molecular Formula | C25H31N3O6 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 6 |
Exact Mass | 469.22128572 g/mol |
Monoisotopic Mass | 469.22128572 g/mol |
Topological Polar Surface Area | 132 Ų |
Heavy Atom Count | 34 |
Formal Charge | 0 |
Complexity | 697 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 3 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Serotonin Antagonists
Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. (See all compounds classified as Serotonin Antagonists.)
Vasoconstrictor Agents
Drugs used to cause constriction of the blood vessels. (See all compounds classified as Vasoconstrictor Agents.)